MRx roundup: J&J’s Janssen ‘Save Legs’ campaign details first-year results; AZ and Lilly both roll new tech tools
J&J’s Janssen is making progress with its peripheral artery disease campaign, “Save Legs. Change Lives,” aimed at reaching Black Americans. Launched a year ago, the three-pronged research, partnership and community effort is raising awareness and promoting screenings to try to decrease PAD-related amputations.
For instance, Janssen’s empowerPAD mobile screening RV-like vehicle is traveling the US and has already provided more than 3,200 non-invasive ankle brachial index (ABI) checks with some surprising results. During one stop in Chicago’s South Side neighborhood, Janssen partnered with a faith-based local group to screen more than 650 people, with an “alarming” 35% receiving a positive test. That’s more than double the national average of 14% — and validation for Janssen’s effort.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.